Glaucoma Associates of Texas, Dallas, TX.
J Glaucoma. 2020 Apr;29(4):e19-e22. doi: 10.1097/IJG.0000000000001453.
To report a series of 3 eyes of 3 children with congenital glaucoma receiving the XEN gel stent implant.
An interventional case series is reported.
Three eyes underwent implantation of the gel stent. In 2 cases, the gel implant procedure was performed after failed trabeculotomy, while in the third eye, primary gel stent implantation was performed. One eye received 2 implants. Three procedures were performed via an ab interno approach while the fourth was performed ab externo. No device-related complications were observed. In all 3 eyes, intraocular pressure was controlled without the use of topical medications through 6 to 24 months of follow-up.
The gel stent implant can be safely used in children with congenital glaucoma and effectively lowers intraocular pressure in these eyes. This procedure is a viable follow-up to, or replacement for, traditional angle surgery in eyes with congenital glaucoma.
报告 3 例儿童先天性青光眼接受 XEN 凝胶支架植入的系列病例。
本研究为一项介入性病例系列研究。
3 只眼接受了凝胶支架植入。2 例在小梁切开术失败后进行了凝胶植入手术,而第 3 只眼则进行了原发性凝胶支架植入。1 只眼接受了 2 次植入。3 只眼通过经内路途径进行了手术,而第 4 只眼则通过经外路途径进行了手术。所有 3 只眼在 6 至 24 个月的随访中均未观察到与器械相关的并发症。在所有 3 只眼中,眼压均得到控制,无需使用局部药物。
凝胶支架植入可安全用于儿童先天性青光眼,并可有效降低这些眼的眼压。对于先天性青光眼的眼睛,该手术可作为传统角度手术的后续治疗或替代方法。